Prudential Financial Inc. lifted its position in Chimera Investment Co. (NYSE:CIM - Free Report) by 79.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,659 shares of the real estate investment trust's stock after purchasing an additional 25,000 shares during the period. Prudential Financial Inc. owned about 0.07% of Chimera Investment worth $793,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. BNP Paribas Financial Markets lifted its position in shares of Chimera Investment by 105.7% in the third quarter. BNP Paribas Financial Markets now owns 36,854 shares of the real estate investment trust's stock valued at $583,000 after acquiring an additional 18,935 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Chimera Investment by 67.3% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 147,621 shares of the real estate investment trust's stock valued at $2,337,000 after buying an additional 59,380 shares in the last quarter. State Street Corp raised its position in shares of Chimera Investment by 0.4% during the third quarter. State Street Corp now owns 1,914,764 shares of the real estate investment trust's stock valued at $31,010,000 after buying an additional 7,595 shares during the last quarter. Jane Street Group LLC lifted its holdings in shares of Chimera Investment by 5.1% in the third quarter. Jane Street Group LLC now owns 141,001 shares of the real estate investment trust's stock worth $2,232,000 after buying an additional 6,803 shares in the last quarter. Finally, Barclays PLC boosted its position in shares of Chimera Investment by 301.6% during the third quarter. Barclays PLC now owns 183,295 shares of the real estate investment trust's stock worth $2,901,000 after acquiring an additional 137,655 shares during the last quarter. 48.44% of the stock is currently owned by institutional investors.
Chimera Investment Trading Down 1.6 %
Shares of NYSE:CIM traded down $0.18 during trading on Friday, hitting $10.70. The company had a trading volume of 764,867 shares, compared to its average volume of 595,093. The stock has a market cap of $865.47 million, a price-to-earnings ratio of 9.90 and a beta of 1.47. The company has a debt-to-equity ratio of 2.82, a current ratio of 0.06 and a quick ratio of 3.03. The company has a fifty day simple moving average of $13.36 and a two-hundred day simple moving average of $14.33. Chimera Investment Co. has a one year low of $9.85 and a one year high of $16.89.
Chimera Investment (NYSE:CIM - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The real estate investment trust reported $0.37 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.10). Chimera Investment had a return on equity of 7.00% and a net margin of 20.28%. As a group, equities analysts forecast that Chimera Investment Co. will post 1.57 earnings per share for the current year.
Chimera Investment Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.37 per share. The ex-dividend date is Monday, March 31st. This represents a $1.48 dividend on an annualized basis and a dividend yield of 13.84%. Chimera Investment's dividend payout ratio is 137.04%.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on CIM. StockNews.com cut Chimera Investment from a "buy" rating to a "hold" rating in a report on Thursday, February 13th. JMP Securities reiterated a "market perform" rating on shares of Chimera Investment in a research report on Thursday, January 23rd. Finally, Royal Bank of Canada upgraded shares of Chimera Investment to a "moderate buy" rating in a research report on Friday, March 14th.
View Our Latest Stock Report on CIM
Insider Transactions at Chimera Investment
In other news, Director Gerard Creagh purchased 12,500 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was purchased at an average price of $13.31 per share, for a total transaction of $166,375.00. Following the completion of the acquisition, the director now owns 138,127 shares of the company's stock, valued at approximately $1,838,470.37. This trade represents a 9.95 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.91% of the company's stock.
Chimera Investment Company Profile
(
Free Report)
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Featured Stories

Before you consider Chimera Investment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chimera Investment wasn't on the list.
While Chimera Investment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.